

Orbital joined life sciences leaders, researchers and growing businesses at Bionow’s BioIgnite conference at Sci-Tech Daresbury on Tuesday 20 October for a day of discussion, networking and collaboration.
Bringing together around 90 delegates under the theme Sparking Growth Through Collaboration, the event explored how stronger partnerships can help scientific innovation progress from early research through to commercial production and patient benefit.
Our Business Development Manager, Alex Gazzaniga, represented Orbital, discussing the practical infrastructure and specialist partnerships needed to support active projects.
Conversations at the event highlighted some of the uncertainties facing life sciences businesses as they look to develop and scale. A recurring concern in our discussions was how the forthcoming Budget could influence spending decisions, particularly for larger projects. This reinforced the importance of businesses, research organisations and specialist partners working together to move projects forward.
Regulatory requirements add another layer of complexity. Moving from research towards commercial production means ensuring that facilities, equipment and supporting infrastructure meet the standards relevant to each application.
Understanding these requirements early can help businesses identify potential barriers and plan their next steps.
These discussions highlighted why infrastructure planning matters from the outset; a familiar consideration in Orbital’s work with laboratory and pharmaceutical customers. Both sectors form a core part of our business, with high-purity gas systems supporting essential research and production processes.
Where processes depend on high-purity gases, gas distribution, point-of-use requirements and installation all need careful consideration to support reliable operation. These requirements can evolve as facilities expand, equipment changes or production increases.
Orbital works with customers to understand their applications and deliver specialist gas systems suited to their needs. By helping businesses address the gas system standards relevant to their projects, we translate process requirements into practical, engineered solutions.
BioIgnite’s emphasis on early collaboration reflects the value of bringing customers, facility teams and specialist suppliers together during planning. This helps identify constraints and account for future demand, particularly when adapting existing facilities or preparing to increase capacity.
BioIgnite offered a valuable opportunity to hear directly about the pressures facing life sciences businesses and discuss how specialist partners can support their next steps. For Orbital, these conversations help us understand the priorities shaping laboratory and pharmaceutical projects.
Thank you to Bionow and everyone involved for bringing the sector together.
Planning a laboratory or pharmaceutical project? Speak to Orbital about the high-purity gas requirements for your project.